Human cloning and embryonic stem cell research after Seoul. [Follow-up questions]

dc.contributor.authorUnited States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
dc.date.accessioned2007-05-23T16:17:55Z
dc.date.available2007-05-23T16:17:55Z
dc.date.issued2006-03-07
dc.description26 pages (out of 249 pages)en
dc.description.abstractFull text of the congressional hearing discussing the ethical issues raised by stem cell research recently conducted in Seoul, South Korea. Issues include human cloning for the purpose of producing human stem cells. [Opening statements] contains the opening statements of the congressional committee. [Battey] contains the testimony and prepared statement of James F. Battey, National Institutes of Health (NIH) Stem Cell Task Force chair. [Schwetz] contains the testimony and prepared statement of Bernard A. Schwetz, director of the Office for Human Research Protections, U.S. Department of Health and Human Services. [Pascal] contains the testimony and prepared statement of Chris B. Pascal, director of the Office of Research Integrity, U.S. Department of Health and Human Services. [Panel 1 questioning] contains the questioning of the first panel, consisting of Battey, Schwetz, and Pascal. [Chole] contains the testimony and prepared statement of stem cell researcher Dr. Richard A. Chole. [Norsigian] contains the testimony and prepared statement of Judy Norsigian, co-author of "Our Bodies Ourselves" and women's health advocate. [Brown] contains the testimony and prepared statement of patient advocate Joe Brown. [Beeson] contains the testimony and prepared statement of Diane Beeson, professor at California State University, East Bay. [Doerflinger] contains the testimony and prepared statement of pro-life advocate Richard M. Doerflinger. [Mathews] contains the testimony and prepared statement of Debra Mathews, scientist and bioethics scholar. [Panel 2 questioning] contains the questioning of the second panel, consisting of Chole, Norsigian, Brown, Beeson, Doerflinger, and Mathews. [Additional information (1)] contains additional information submitted. [Follow-up questions] contains follow-up questions for both panels. [Uniform requirements for manuscripts] contains the document "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication." [Hinxton Group] contains a statement from The Hinxton Group, "An International Consortium on Stem Cells, Ethics, and Law." [Values in conflict] contains the document "Values in Conflict: Public Attitudes on Embryonic Stem Cell Research." [Additional information (2)] contains additional information submitted.en
dc.format.extent1592119 bytes
dc.format.mimetypeapplication/pdf
dc.identifier.citationUnited States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources. (2006). Human cloning and embryonic stem cell research after Seoul. Retrieved February 20, 2007, from the U.S. Government Printing Office web site: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_house_hearings&docid=29580.wais.pdfen
dc.identifier.urihttps://hdl.handle.net/1805/917
dc.language.isoen_USen
dc.publisherU.S. Government Printing Officeen
dc.relation.ispartofseriesSerial no. 109-169en
dc.subjectstem cell researchen
dc.subjecthuman cloningen
dc.subjecthuman embryonic stem cellsen
dc.subject.lcshEmbryonic stem cells -- Researchen
dc.subject.lcshHuman cloningen
dc.subject.nrcblStem Cell Research. 18.5.4en
dc.subject.nrcblCloning. 14.5en
dc.subject.nrcblScientific Research Ethics. 1.3.9en
dc.titleHuman cloning and embryonic stem cell research after Seoul. [Follow-up questions]en
dc.typeOtheren
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Follow-up questions.pdf
Size:
1.52 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.94 KB
Format:
Item-specific license agreed upon to submission
Description: